How Often Do You Need Allergy Shots? Medical Necessity by Patient Type

If you are sensitized to multiple allergens — particularly 5 or more — you may need 2 injections per clinic visit rather than 1. This happens when your allergen extracts cannot be safely combined in a single vial due to enzymatic incompatibility (for example, mixing cockroach extracts with dust mite extracts can degrade both). Two-injection patients receive one shot in each arm per visit, with at least 30 minutes between injections from different vials, per AAAAI safety parameters. This doubles the injection count per visit but not the number of trips to the clinic. Your visit frequency — 1-2x/week build-up, then every 2-4 weeks maintenance — remains the same. Some practices consolidate allergens into single mixed vials when compatibility allows.

Children and adults typically receive allergy shots at the same frequency — 1-2 visits per week during build-up and every 2-4 weeks during maintenance. However, some pediatric allergists prefer biweekly maintenance (every 2 weeks) rather than monthly for children in their first year of maintenance, to allow closer monitoring of tolerability and to communicate more frequently with the child and family. The PAT study (Jacobsen et al., Allergy 2007) showed that completing 3 years of SCIT in children significantly reduced the risk of asthma development over 7 years of follow-up, supporting the same duration recommendation as adults. The 30-minute post-injection observation period applies equally and is just as mandatory for children.

Patients with asthma do not necessarily need more frequent allergy shots than those without, but they require more careful assessment at each visit. Pre-injection peak flow measurement is standard of care for asthmatic SCIT patients; injections are withheld if FEV1 is below 70% of predicted to minimize systemic reaction risk. Some allergists prefer biweekly maintenance rather than monthly for patients with both severe rhinitis and moderate-to-severe asthma, to maintain more consistent allergen tolerance during high-allergen seasons. Poorly controlled asthma is a contraindication to receiving any immunotherapy injection until asthma is stabilized. Active asthma exacerbation — wheeze, tightness, or peak flow below 80% — means the injection should be postponed.

Elderly patients (65 and older) generally follow the same injection frequency as younger adults — 1-2x/week during build-up and every 2-4 weeks during maintenance. The primary adjustment is not frequency but duration: Bozek et al. (Clin Int Aging 2016) noted that older patients may experience slower immune adaptation and may need longer treatment duration — 4-5 years rather than 3 years — to achieve the same level of disease modification. There is limited evidence specifically supporting modified frequency protocols for elderly patients. However, some allergists use longer inter-visit intervals during build-up for elderly patients, particularly if comorbidities such as cardiovascular disease increase the risk profile of systemic reactions.

The severity of your IgE sensitization influences protocol design but not necessarily visit frequency in a straightforward way. Highly sensitized patients may begin build-up at a much lower starting concentration, requiring more dose-escalation steps to reach the maintenance level — which can effectively extend the build-up phase even at standard weekly frequency. Patients with moderate sensitization may reach maintenance faster. Importantly, patients who have had prior systemic reactions during build-up will need more gradual dose escalation — more visits at the same frequency but with smaller dose increments per step. Your allergist uses your skin test reactivity and specific IgE levels at initial evaluation to design a dose escalation plan appropriate for your sensitization level.

Yes — patients with occupational allergen exposures may benefit from more frequent maintenance injections than the standard monthly schedule. Veterinarians, laboratory animal workers, bakers (flour dust allergy), and farmers face ongoing daily high-dose natural allergen exposure that continuously challenges their immune tolerance. For these patients, some allergists recommend biweekly rather than monthly maintenance to sustain adequate IgG4 blocking antibody levels against the heavy allergen load of their workplace. This clinical adjustment is not universally standardized in published guidelines but reflects the logical application of dose-frequency principles: higher ambient allergen exposure may require higher treatment frequency to maintain adequate immunological protection.